United States - English - NLM (National Library of Medicine)

bamf health inc. - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - sodium fluoride f 18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fluoride f 18 injection or not to administer sodium fluoride f 18 injection, taking into account the importance of the drug to the mother. the body of scientific information related to radioactive decay, drug tissue distribution, and drug elimination shows that less than 0.01% of the radioactivity administered remains in the body after 24 hours (10 half-lives). to minimize the risks to a nursing infant, interrupt nursing for at least 24 hours. in reported clinical experience in approximately 100 children, weight based doses (2.1 mbq/kg) ranging from 19 mbq-148 mbq (0.5 mci-4 mci) were used. sodium fluoride f 18 was shown to localize to areas of bone turnover including rapidly growing epiphyses in developing long bones. children are more sensitive to radiation and may be at higher risk of cancer from sodium fluoride f 18 injection.

Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun medical limited - sodium chloride; potassium chloride; sodium lactate solution; calcium chloride dihydrate - solution for infusion - 6/6.24/0.40/0.27 %v/v - solutions affecting the electrolyte balance; electrolytes

United States - English - NLM (National Library of Medicine)

puretek corporation - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o), vitamin a (unii: 81g40h8b0t) (vitamin a - unii:81g40h8b0t), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), sodium ascorbate (unii: s033eh8359) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (.alpha.-tocopherol, dl- - unii:7qwa1rio01), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j94 - fluoride ion 0.5 mg - supplementation of the diet with ten essential vitamins. supplementation of the diet with fluoride for caries prophylaxis. the american academy of pediatrics recommends that children up to the age 16, in areas where drinking water contains less than optimal levels of fluoride, receive daily fluoride supplementation. multivitamin with fluoride 0.5 mg chewable tablets provide 0.5 mg fluoride in tablet form for children 4-6 years of age in areas where the drinking water fluoride level is less than 0.3 ppm, and for children 6 years of age and above where the drinking water contains 0.3 through 0.6 ppm of fluoride. multivitamin with fluoride 0.5 mg chewable tablets supply significant amounts of vitamins a, c, d, e, thiamine, riboflavin, niacin, vitamin b6, vitamin b12, and folate to supplement the diet, and to help assure that nutritional deficiencies of these vitamins will not develop. thus, in a single easy-to-use preparation, children obtain ten essential vitamins and the im

United States - English - NLM (National Library of Medicine)

mayne pharma inc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.5 mg in 1 ml - it has been established that ingestion of fluoridated drinking water (1 ppm f) during the period of tooth development results in significant decrease in the incidence of dental caries. sodium fluoride drops 0.5 mg were developed to provide systemic fluoride for use as a supplement in pediatric patients from 6 months to age 3 and older, living in areas where the drinking water fluoride level does not exceed 0.6 ppm f. do not use in areas where drinking water exceeds 0.6 ppm f. do not administer to pediatric patients less than 6 months old.

United States - English - NLM (National Library of Medicine)

dentsply professional - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 27.3 mg in 1 g - for topical application to aid in the protection against dental caries. hypersensitivity to fluoride. acidulated phosphate fluoride should not be used for patients with porcelain, composite restorations and sealants.

United States - English - NLM (National Library of Medicine)

target corp. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 0.2 mg in 1 ml - anticavity aids in the prevention of dental cavities

United States - English - NLM (National Library of Medicine)

dentsply llc. professional division trading as "dentsply professional" - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - fluoride ion 20 mg in 1 g - for topical application to aid in the protection against dental caries. the non-acidic fluoride is safe for patients with porcelain, composite restorations, and sealants. hypersensitivity to fluoride

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bracco uk ltd - sulfur hexafluoride - powder and solvent for dispersion for injection - 8microlitre/1ml

Israel - English - Ministry of Health

dexcel ltd, israel - sulphur hexafluoride - powder and solvent for dispersion for injection - sulphur hexafluoride 8 mcl/ml - sulfur hexafluoride - this medicinal product is for diagnostic use only. sonovue is for use with ultrasound imaging to enhance the echogenicity of the blood, which results in an improved signal to noise ratio. sonovue should only be used in patients where study without contrast enhancement is inconclusive.echocardiography: sonovue is a transpulmonary echocardiographic contrast agent for use in patients with suspected or established cardiovascular disease to provide opacification of cardiac chambers and enhance left ventricular endocardial border delineation.doppler of macrovasculature: sonovue increases the accuracy in detection or exclusion of abnormalities in cerebral arteries and extracranial carotid or peripheral arteries by improving the doppler signal to noise ratio. sonovue increases the quality of the doppler flow image and the duration of clinically useful signal enhancement in portal vein assessment.doppler of microvasculature: sonovue improves display of the vascularity of liver and breast lesions during doppler sonography, leading to more specific lesion characterisation.

New Zealand - English - Medsafe (Medicines Safety Authority)

noumed pharmaceuticals limited - sodium fluoride 1.1mg equivalent to 0.5 mg elemental fluoride;   - tablet - 1.1 mg - active: sodium fluoride 1.1mg equivalent to 0.5 mg elemental fluoride   excipient: lactose monohydrate magnesium stearate maize starch - fluoride supplement